NEW YORK (GenomeWeb News) – Pacific Biosciences is closing in on a settlement over a class action lawsuit related to its initial public offering, the company has confirmed to GenomeWeb Daily News.

On October 25, a hearing will be held in Superior Court of California, County of San Mateo before Judge Marie Weiner to determine whether a settlement between PacBio and plaintiffs will be approved. The amount of the settlement is for "at least" approximately $7.7 million, the plaintiffs' lawyers said in a notice about the court hearing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.